Emerging Trends: Decentralised to Home-based Clinical Trials

The landscape of cancer care is evolving, with startups changing the field by bringing care to patients' homes. Innovative companies are addressing the barriers to patient centricity and convenience by offering home infusions, lab draws, and virtual visits. Advancements in screening and diagnosis are making home-based cancer care more feasible, enabling earlier detection and accurate monitoring. This leads to better treatment outcomes and fewer hospital visits for patients.   

Recognising the vulnerability of immunocompromised cancer patients, the shift towards decentralised care is crucial to minimise the risk of hospital-acquired infections and exposure to other sick patients. In line with this trend, decentralised clinical trial companies are emerging, enabling home-based clinical trials.  

But are we ready to embrace a future where cancer care and research unfold within the familiar walls of our homes?  

Join this discussion with your peers and dig into: 

• What factors are driving decentralised and home-based trials? 
• How can we leverage technologies such as telemedicine and remote monitoring, to improve patient engagement and adherence to treatment plans in home-based cancer care?  
• Which pharmaceutical companies are actively exploring and driving innovation in this space?